Gianvi Tagged Articles

Judge orders birth control pill makers to turn over files for litigation
Posted: June 22, 2010 Pharmaceutical

District Judge David Herndon is ordering sales representatives who pushed the oral contraceptives Yasmin, Yaz, Ocella and Gianvi to produce all their files and communications for national litigation. The order covers “all written materials, video and/or audio tapes” and includes

Bayer, Teva rival birth control pills go head-to-head in court
Posted: June 21, 2010 Pharmaceutical

Things are getting even uglier between two pharmaceutical companies whose oral contraceptives will soon go head-to-head in America. First, Bayer announced it was suing Teva Pharmaceutical Industries for prematurely pushing Gianvi, its generic version of Bayer’s blockbuster birth control pill

Bayer sues Teva for prematurely marketing generic Yaz
Posted: June 7, 2010 Pharmaceutical

Bayer’s multimillion dollar birth control pill, Yaz, will go head-to-head with generic competition with the introduction of Teva Pharmaceutical Industries’ Gianvi. Teva was awarded a 180-day marketing exclusivity period for Gianvi by the Food and Drug Administration after being the